Cargando…
Temozolomide resistance in glioblastoma cells occurs partly through epidermal growth factor receptor-mediated induction of connexin 43
Glioblastoma Multiforme (GBM) is an aggressive adult primary brain tumor with poor prognosis. GBM patients develop resistance to the frontline chemotherapy, temozolomide (TMZ). As the connexins (Cx) have been shown to have a complex role in GBM, we investigated the role of Cx43 in TMZ resistance. Cx...
Autores principales: | Munoz, J L, Rodriguez-Cruz, V, Greco, S J, Ramkissoon, S H, Ligon, K L, Rameshwar, P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973225/ https://www.ncbi.nlm.nih.gov/pubmed/24675463 http://dx.doi.org/10.1038/cddis.2014.111 |
Ejemplares similares
-
Temozolomide resistance in glioblastoma occurs by miRNA-9-targeted PTCH1, independent of sonic hedgehog level
por: Munoz, Jessian L., et al.
Publicado: (2015) -
Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell–derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity
por: Munoz, Jessian L, et al.
Publicado: (2013) -
Exosomal connexin 43 regulates the resistance of glioma cells to temozolomide
por: Yang, Zhang-Jian, et al.
Publicado: (2021) -
Cycling Quiescence in Temozolomide Resistant Glioblastoma Cells Is Partly Explained by microRNA-93 and -193-Mediated Decrease of Cyclin D
por: Munoz, Jessian L., et al.
Publicado: (2019) -
Connexin 43 peptidic medicine for glioblastoma stem cells
por: Sheng, Zhi
Publicado: (2021)